Blue Jet Healthcare Limited (BLUEJET) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹541.9 (-4.92% day change)
Key ratios
- P/E ratio
- 37.92
- P/B ratio
- 4.17
- ROE (%)
- 18.22
- ROCE (%)
- 19.11
- Debt/Equity
- 0.03
- Dividend yield (%)
- 0.37
- Market cap (₹ Cr)
- 9,400.09
Forensic checks
Piotroski F-Score: 5/9 · Altman Z-Score: 12.35 · Beneish M-Score: -1.84
InvestSights quality score
65.8/100 — Above Average (descriptive data-driven composite; not a recommendation)
Management guidance track record
- Mahad Unit 3 CAPEX: guided 300Rs Cr, delivered 135Rs Cr (Q2 FY26) — missed guidance
- Normalised gross margin: guided 53%, delivered 53% (9M FY26) — met guidance
Latest earnings call (Q1 FY27)
AI summary: The single most important signal from this concall is the confirmed restart and sustained visibility of the PI/API (Bempedoic acid cardiovascular intermediate) business, which drove a 25% sequential revenue recovery to ₹293 crores and EBITDA margin expansion to 33.5%. Management provided explicit 3–4 quarter forward order visibility for this segment — a meaningful departure…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.